相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?
P. Avari et al.
DIABETIC MEDICINE (2020)
A critical review and analysis of ethical issues associated with the artificial pancreas
A. Quintal et al.
DIABETES & METABOLISM (2019)
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial
Martin Tauschmann et al.
DIABETES CARE (2019)
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home
Torben Biester et al.
DIABETES OBESITY & METABOLISM (2019)
Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development
Sunil Deshpande et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes
Gregory P. Forlenza et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis
Vasilios Karageorgiou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study
Pierre Yves Benhamou et al.
ACTA DIABETOLOGICA (2018)
Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors
Jessica R. Castle et al.
DIABETES CARE (2018)
Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial
Zoe A. Stewart et al.
DIABETES CARE (2018)
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting
Gregory P. Forlenza et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes
Halis Kaan Akturk et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review
C. Farrington
DIABETIC MEDICINE (2018)
Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results
Chiara Toffanin et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2018)
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story
Lia Bally et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care
Lia Bally et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
Eleni Bekiari et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
Eleni Bekiari et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Xia Dai et al.
DIABETES THERAPY (2018)
Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Xia Dai et al.
DIABETES THERAPY (2018)
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
Gregory P. Forlenza et al.
DIABETES CARE (2018)
Performance of Medtronic Hybrid Closed-Loop Iterations, Results from a Randomized Trial in Adolescents with Type 1 Diabetes
Martin de Bock et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Martin Tauschmann et al.
LANCET (2018)
Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes
Jenine Y. Stone et al.
THERAPEUTIC DELIVERY (2018)
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
Firas H. El-Khatib et al.
LANCET (2017)
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
Lia Bally et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
Hood Thabit et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach
Sverre Christian Christiansen et al.
DIABETES THERAPY (2017)
A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach
Sverre Christian Christiansen et al.
DIABETES THERAPY (2017)
Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study
Eyal Dassau et al.
DIABETES OBESITY & METABOLISM (2017)
Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial
Gregory P. Forlenza et al.
DIABETES CARE (2017)
Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial
Ahmad Haidar et al.
DIABETES OBESITY & METABOLISM (2017)
Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors
Timothy S. Bailey
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Tim Heise et al.
CLINICAL PHARMACOKINETICS (2017)
MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial
Revital Nimri et al.
DIABETES OBESITY & METABOLISM (2017)
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
Satish K. Garg et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
GLP-1 Agonists in Type 1 Diabetes Mellitus
Kristin M. Janzen et al.
ANNALS OF PHARMACOTHERAPY (2016)
Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association
Deborah Young-Hyman et al.
DIABETES CARE (2016)
Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas
Jordan E. Pinsker et al.
DIABETES CARE (2016)
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
Martin Tauschmann et al.
DIABETES CARE (2016)
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial
Martin Tauschmann et al.
DIABETES CARE (2016)
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home
Eric Renard et al.
DIABETES CARE (2016)
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
Rose A. Gubitosi-Klug et al.
DIABETES CARE (2016)
Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide
Jennifer L. Sherr et al.
DIABETES CARE (2016)
Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes
Zoe A. Stewart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges
Andrea Facchinetti
SENSORS (2016)
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
Cornelis A. J. van Beers et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial
Steven J. Russell et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Role of Amylin in Type 1 and Type 2 Diabetes
Laura Hieronymus et al.
DIABETES EDUCATOR (2015)
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Boris P. Kovatchev et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2015)
Psychosocial aspects of closed-and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting
K. D. Barnard et al.
DIABETIC MEDICINE (2015)
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial
Ahmad Haidar et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2015)
Feasibility of Closed- Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study
Kavita Kumareswaran et al.
DIABETES CARE (2014)
Closed- Loop Artificial Pancreas Systems: Engineering the Algorithms
Francis J. Doyle et al.
DIABETES CARE (2014)
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
Katharine D. Barnard et al.
BMJ OPEN DIABETES RESEARCH & CARE (2014)
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
Richard M. Bergenstal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
Lalantha Leelarathna et al.
CRITICAL CARE (2013)
Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
Stuart A. Weinzimer et al.
DIABETES CARE (2012)
The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences
P. D. Home
DIABETES OBESITY & METABOLISM (2012)
Hypoglycaemia during pregnancy in women with Type 1 diabetes
L. Ringholm et al.
DIABETIC MEDICINE (2012)
The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients
Tomoaki Yatabe et al.
CRITICAL CARE MEDICINE (2011)
Artificial Pancreas Past, Present, Future
Claudio Cobelli et al.
DIABETES (2011)
Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery Feasibility study testing a new model for the artificial pancreas
Eric Renard et al.
DIABETES CARE (2010)
Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction
A. Garcia-Patterson et al.
DIABETOLOGIA (2010)
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
J. C. Pickup et al.
DIABETIC MEDICINE (2008)
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis
K. Jeitler et al.
DIABETOLOGIA (2008)
Benefits and risks of tight glucose control in critically ill adults - A meta-analysis
Renda Soylemez Wiener et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients
Eric Renard et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Closed-loop insulin delivery - the path to physiological glucose control
GM Steil et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
F Whitehouse et al.
DIABETES CARE (2002)
Intensive insulin therapy in critically ill patients.
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
